SEMA4C as a Relapse Biomarker in Breast Cancer
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: OTHER: SEMA4C high value follow-up group|OTHER: SEMA4C low value follow-up group
Sponsor: Tongji Hospital
Collaborators: Hubei Cancer Hospital|Qilu Hospital of Shandong University|Wuhan Central Hospital|Xiangyang Central Hospital|The First People's Hospital of Jingzhou|The First Affiliated Hospital with Nanjing Medical University